tiprankstipranks
Trending News
More News >
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Income Statement

Compare
585 Followers

Trevi Therapeutics Income Statement

Last quarter (Q3 2025), Trevi Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Trevi Therapeutics's net income was $-11.80M. See Trevi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -147.00K$ 0.00$ 0.00$ -50.00K$ -47.00K
Operating Expenses
$ 51.52M$ 33.92M$ 29.91M$ 32.48M$ 32.49M
Depreciation and Amortization
$ 147.00K$ 123.00K$ 43.00K$ 50.00K$ 47.00K
EBITDA
$ -47.79M$ -28.58M$ -27.98M$ -32.71M$ -32.27M
Operating Income
$ -51.52M$ -33.92M$ -29.91M$ -32.48M$ -32.49M
Other Income/Expenses
$ 3.58M$ 4.83M$ 719.00K$ -1.49M$ -287.00K
Pretax Income
$ -47.94M$ -29.10M$ -29.19M$ -33.96M$ -32.78M
Net Income
$ -47.91M$ -29.07M$ -29.15M$ -33.94M$ -32.76M
Per Share Metrics
Basic EPS
$ -0.47$ -0.29$ -0.45$ -1.49$ -1.81
Diluted EPS
$ -0.47$ -0.29$ -0.45$ -1.49$ -1.81
Weighted Average Shares Outstanding
101.04M 99.03M 64.54M 22.84M 18.06M
Weighted Average Shares Outstanding (Diluted)
101.04M 99.03M 64.54M 22.84M 18.06M
Currency in USD

Trevi Therapeutics Earnings and Revenue History